Fleming Island

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Prostate cancer1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alnylam Pharmaceuticals3 trials
• Arvinas Inc.1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting

Closed trials

• Completed

  A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

  NCT04936035· Phase 2· Alnylam Pharmaceuticals· Source

• Terminated

  A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

  NCT04565717· Phase 1· Alnylam Pharmaceuticals· Source

• Completed

  Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

  NCT03888612· Phase 1/2· Arvinas Inc.· Source